The objective of the study is to gather post-market data regarding the performance of the invendo SC20 colonoscope in a real-world US population.
The objective of the study is to expand data collection and product exposure in a controlled clinical setting and gather data regarding the performance of the Invendo SC20 colonoscope in a real-world US population. The objective of the study is to specifically monitor three points: 1. The diagnostic performance of the device including polyp and adenoma detection rates; 2. The therapeutic performance of the device (the ability of the physician to remove/biopsy identified lesions); 3. Performance of the device in a typical colonoscopy population, including patients with underlying inflammatory bowel disease (IBD), previous pelvic surgery or irradiation, obesity, diverticular disease, and previous colorectal surgery, as they present in the study population (see below C.).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SCREENING
Masking
NONE
Enrollment
2
Single Arm Post-Marketing Study of SC20 Colonoscope
Bellevue Hospital Center
New York, New York, United States
NYU Langone Medical Center Ambulatory care
New York, New York, United States
New York Presbyterian Columbia University Medical Center
New York, New York, United States
1. Cecal intubation rates (visualization of the cecum by notation of landmarks and photo documentation of landmarks in every procedure)
Time frame: average 6 to 12 months
2. Detection of polyps, adenomas and other lesions in all individuals
Time frame: average 6 to 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.